How many SC 13D/A filings has Janux Therapeutics, Inc. filed?

Janux Therapeutics, Inc. (JANX) has 8 SC 13D/A (SC 13D/A) filings on record, spanning Mar 2024 to Nov 2024.

What is a SC 13D/A filing?

A SC 13D/A is an SEC filing known as "SC 13D/A." It is filed with the SEC as a SC 13D/A.

Where can I read Janux Therapeutics, Inc. SC 13D/A filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Janux Therapeutics, Inc. SC 13D/A filings, including risk assessment, sentiment analysis, and key financial figures.

Janux Therapeutics, Inc. (JANX) — SC 13D/A Filings

All SC 13D/A filings from Janux Therapeutics, Inc.. Browse 8 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (8)

Avalon Ventures XI Amends Janux Therapeutics Stake — Nov 8, 2024 Risk: medium
Avalon Ventures XI, L.P. and its affiliates have amended their Schedule 13D filing regarding Janux Therapeutics, Inc. as of November 8, 2024. The filing indicat
Avalon Ventures XI Amends Janux Therapeutics Stake — Oct 25, 2024 Risk: medium
Avalon Ventures XI, L.P. and its affiliates have amended their Schedule 13D filing regarding Janux Therapeutics, Inc. as of October 25, 2024. The filing indicat
Avalon Ventures XI Updates Janux Therapeutics Stake — Oct 22, 2024 Risk: medium
Avalon Ventures XI, L.P. and its affiliates have filed an amendment (No. 5) to their Schedule 13D regarding Janux Therapeutics, Inc. as of October 22, 2024. The
RA Capital Amends Janux Therapeutics Filing — Sep 16, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and RA Capital Healthcare Fund, L.P., have amended their Schedule 13D filing for Janu
OrbiMed Amends Janux Therapeutics Stake Filing — Aug 9, 2024 Risk: medium
OrbiMed Advisors LLC and its affiliates have amended their Schedule 13D filing regarding Janux Therapeutics, Inc. as of August 9, 2024. The filing indicates a c
Avalon Ventures Adjusts Janux Therapeutics Stake — Jun 5, 2024 Risk: medium
Avalon Ventures XI, L.P. and its affiliates have amended their Schedule 13D filing regarding Janux Therapeutics, Inc. as of June 5, 2024. The filing indicates a
RA Capital Amends Janux Therapeutics Stake Filing — Mar 6, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and RA Capital Healthcare Fund, L.P., have amended their Schedule 13D filing regardin
Avalon Ventures XI Adjusts Janux Therapeutics Stake — Mar 4, 2024 Risk: medium
On March 4, 2024, Avalon Ventures XI, L.P. filed an amendment to its Schedule 13D, reporting a change in beneficial ownership of Janux Therapeutics, Inc. The fi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX